Krane Funds Advisors LLC Burning Rock Biotech LTD Transaction History

Krane Funds Advisors LLC

  • $2.45 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$6.7 - $10.23 $938 - $1,432
-140 Closed
0 $0
Q4 2021

Feb 10, 2022
SELL
$9.43 - $17.14 $233,232 - $423,923
-24,733 Reduced 99.44%
140 $1,000
Q3 2021

Nov 12, 2021
SELL
$17.37 - $27.92 $26,610 - $42,773
-1,532 Reduced 5.8%
24,873 $445,000
Q2 2021

Aug 12, 2021
BUY
$26.14 - $37.45 $690,226 - $988,867
26,405 New
26,405 $778,000

Others Institutions Holding BNR

# of Institutions
1
Shares Held
21.2K
Call Options Held
0
Put Options Held
0
View Full List

About Burning Rock Biotech Ltd

BNR Quotes by TradingView
  • Ticker BNR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 105,188,000
  • Market Cap $705M
  • Description
  • Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...
More about BNR
Track This Portfolio

Track Krane Funds Advisors LLC Portfolio

Follow Krane Funds Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krane Funds Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krane Funds Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email